ArticleFrontiers in oncology2024

Treatment with palbociclib and tislelizumab for CDKN2A-mutated and PD-L1-positive advanced intrahepatic cholangiocarcinoma: a case report and literature review.

Yajun Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.